The HOPE Act would amend the 21st Century Cures Act to clarify that certain state and tribal grants may be used for activities related to public access opioid overdose reversal kits, including acquiring, making available, and maintaining these kits. The bill also defines what counts as a public access opioid overdose reversal kit and reorganizes certain subsections to accommodate the new language.
This change focuses on expanding the practical use of existing grant funds to support life-saving equipment and training in communities affected by opioid use disorders.
At a Glance
What It Does
Amends Section 1003 of the 21st Century Cures Act to authorize grant funds for acquiring, making available, and maintaining public access opioid overdose reversal kits. It also adds a formal definition for the kit and adjusts subsection numbering to fit the new text.
Who It Affects
States, tribal health programs, and grant recipients that deploy opioid-use-disorder responses, including community organizations distributing naloxone kits and the vendors that supply them.
Why It Matters
Provides policy clarity and a concrete path to fund widespread access to overdose reversal resources, potentially accelerating life-saving kit distribution in communities with high overdose risk.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill tightens and clarifies how federal grant money under the 21st Century Cures Act can be used to support opioid overdose prevention. Specifically, it adds public access opioid overdose reversal kits to the list of activities that state and tribal grant funds may cover, including the acquisition, availability, and ongoing maintenance of these kits.
To ensure consistent understanding across programs, the bill defines what constitutes a public access overdose reversal kit as one that includes an opioid reversal medication and instructions on how to administer it. In addition, the amendment reorganizes certain subsections to accommodate the new use and the new definition, ensuring the changes fit within the existing statutory structure.
The changes are focused on policy clarity and operational impact, not on creating new funding or programs. For compliance teams, the bill signals that grant portfolios may include procurement and distribution of reversal kits, along with necessary training and maintenance activities, as part of state and tribal responses to opioid use disorders.
The Five Things You Need to Know
The bill allows state and tribal grants to cover acquiring, making available, and maintaining public access opioid overdose reversal kits.
A new definition for 'public access opioid overdose reversal kit' is added: a kit containing an opioid reversal medication and instructions for administration.
Section 1003's (b)(4)(A) text is amended to include 'other activities related to acquiring, making available, and maintaining' these kits.
Subsection numbering within the affected sections is reorganized to accommodate the new definitions and uses.
The HOPE Act provides clarity on grant use without creating new funding or new programs.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title — HOPE Act
This section designates the act as the Having Overdose Protection Equipment Act, or the HOPE Act. It sets up the framework for amendments to the 21st Century Cures Act that follow, signaling a focused policy shift toward enabling public access overdose reversal resources through existing grant programs.
Use of State and Tribal Grant Funds for public access overdose reversal kits
Section 1003 of the 21st Century Cures Act is amended to add a new allowance: grants may be used for acquiring, making available, and maintaining public access opioid overdose reversal kits, expanding the set of activities that grant funds may cover beyond primary prevention. This broadens the operational scope of grant programs to support rapid deployment of reversal resources in communities at risk.
Definition of public access opioid overdose reversal kit
The bill adds a formal definition: a public access opioid overdose reversal kit is a kit that includes an opioid reversal medication and instructions on how to administer it. This definitional element creates a concrete category for procurement, training, and inventory management within grant-funded activities.
Section structure and numbering changes
The amendments restructure subsection numbering within Section 1003 to accommodate the new language. Paragraphs are renumbered and repositioned (and the new definition is inserted in the appropriate place) to ensure the changes are coherently integrated into the existing statutory framework.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- State and territorial public health departments gain a clear, permissible use for grants to fund naloxone kits and related deployment activities, aligning funding with on-the-ground overdose prevention needs.
- Tribal health programs receive explicit authority to use grants for access to reversal kits, supporting health equity in tribal communities with overdose risk.
- Community-based organizations and syringe/overdose prevention programs can procure and maintain kits more reliably, enhancing local outreach and training.
- Naloxone manufacturers and kit distributors may experience steadier demand and clearer procurement pathways through grant-funded programs.
- Hospitals and clinics engaged in grant-backed prevention efforts can participate in kit distribution and education initiatives.
Who Bears the Cost
- State and tribal grant recipients bear administrative and logistical responsibilities to implement kit procurement, inventory management, and distribution under the updated scope.
- Local health departments and community partners may face startup or ongoing costs related to inventory, storage, and staff training for kit use.
- Funding authorities must ensure grant budgets reflect the expanded allowed activities to avoid misallocation within existing programs.
Key Issues
The Core Tension
The central dilemma is balancing broader access to life-saving overdose reversal resources with the need to maintain strict fiscal stewardship of grant funds and ensure that expanded uses align with primary program objectives.
The amendment increases the practical scope of grant-funded activities by explicitly permitting the procurement, distribution, and maintenance of public access opioid overdose reversal kits. This can accelerate life-saving interventions in communities but relies on robust grant management and oversight to avoid scope creep or misallocation of funds intended for broader opioid response activities.
While the bill clarifies what counts as a reversal kit, it does not introduce new funding or create separate programmatic streams, so jurisdictions will need to map these activities to existing grant budgets. In implementation, jurisdictions should consider supply chain reliability, storage requirements for reversal medications, training for correct administration, and consistent reporting to demonstrate outcomes and appropriate use of funds.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.